- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- May 2024
- 164 Pages
Global
From €5178EUR$5,450USD£4,454GBP
- Report
- September 2023
- 145 Pages
Global
From €2374EUR$2,499USD£2,042GBP
- Report
- January 2024
- 200 Pages
Global
From €3943EUR$4,150USD£3,392GBP
- Report
- June 2023
- 158 Pages
Global
From €2375EUR$2,500USD£2,043GBP
- Report
- September 2023
- 124 Pages
North America
From €2564EUR$2,699USD£2,206GBP
- Report
- March 2024
- 194 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- October 2023
- 75 Pages
Global
From €5653EUR$5,950USD£4,863GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1900EUR$2,000USD£1,634GBP
- Report
- October 2023
- 186 Pages
Global
From €5225EUR$5,500USD£4,495GBP
- Report
- March 2024
- 181 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- March 2024
- 186 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- May 2023
- 169 Pages
Global
From €2233EUR$2,350USD£1,921GBP
- Report
- March 2024
- 195 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- January 2024
- 150 Pages
Global
From €4608EUR$4,850USD£3,964GBP
- Report
- October 2023
- 185 Pages
Global
From €4655EUR$4,900USD£4,005GBP
- Report
- November 2023
- 177 Pages
Global
From €4655EUR$4,900USD£4,005GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1900EUR$2,000USD£1,634GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1900EUR$2,000USD£1,634GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1425EUR$1,500USD£1,226GBP
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more